MYOS RENS Technology Inc. (MYOS:NASDAQ) Annual Reports & Investor Relations Material

Overview

MYOS RENS Technology Inc. is a New Jersey-based advanced nutrition company that focuses on developing and marketing products to improve muscle health and performance. The company's main product is Fortetropin, an advanced nutrition supplement made from fertilized egg yolk-based product manufactured via a proprietary process that retains and optimizes its biological activity. This product has been clinically proven to increase muscle size, lean body mass, and reduce muscle atrophy. MYOS RENS Technology believes that Fortetropin has the potential to redefine the existing standards of physical health and wellness.

Frequently Asked Questions

What is MYOS RENS Technology Inc.'s ticker?

MYOS RENS Technology Inc.'s ticker is MYOS

What exchange is MYOS RENS Technology Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are MYOS RENS Technology Inc.'s headquarters?

They are based in Cedar Knolls, New Jersey

How many employees does MYOS RENS Technology Inc. have?

There are 11-50 employees working at MYOS RENS Technology Inc.

What is MYOS RENS Technology Inc.'s website?

It is https://www.myosrens.com/

What type of sector is MYOS RENS Technology Inc.?

MYOS RENS Technology Inc. is in the Healthcare sector

What type of industry is MYOS RENS Technology Inc.?

MYOS RENS Technology Inc. is in the Drug Manufacturers - Other industry

Who are MYOS RENS Technology Inc.'s peers and competitors?

The following five companies are MYOS RENS Technology Inc.'s industry peers:

- Elite Pharmaceuticals Inc

- MediaValet

- SCYNEXIS

- Endo International

- The Supreme Cannabis Company, Inc.